An Open-Label, Rater-Blinded, Flexible-Dose, 8-Week Trial of Escitalopram in Patients With Major Depressive Disorder With Atypical Features

Objectives: Although selective serotonin reuptake inhibitors (SSRIs) have become the standard of care for the treatment of major depressive disorder (MDD), limited data exist to support their use in MDD with atypical features. The current study investigates the efficacy of the SSRI escitalopram in a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Pae, Chi-Un, Masand, Prakash S., Peindl, Kathleen, Mannelli, Paolo, Han, Changsu, Marks, David M., Patkar, Ashwin A.
Formato: Artigo
Idioma:Inglês
Publicado: Physicians Postgraduate Press, Inc. 2008
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2446493/
https://ncbi.nlm.nih.gov/pubmed/18615172
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares